Showing results (271-280 of 299) with videos related to

Sort By:
Pageof 30
Journal of Cancer Research and Clinical Oncology|October 21, 2006
Evaluation of different protocols for gene transfer into non-obese diabetes/severe combined immunodeficiency disease mouse repopulating cellsPeter Ebeling, P Bach, U Sorg, et al.
British Journal of Haematology|March 1, 1993
Impact of interferon alpha-induced cytogenetic improvement on survival in chronic myelogenous leukaemiaO Kloke, N Niederle, J Y Qiu, et al.
British Journal of Haematology|August 1, 1992
Combination therapy with interferon alpha-2b plus low-dose interferon gamma in pretreated patients with Ph-positive chronic myelogenous leukaemiaU B Wandl, O Kloke, M Nagel-Hiemke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2002
Induction chemotherapy followed by concurrent chemotherapy and definitive high-dose radiotherapy for patients with locally advanced non-small-cell lung cancer (stages IIIa/IIIb): a pilot phase I/II trialC Pöttgen, W Eberhardt, S Bildat, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Tumor necrosis factor alpha modifies resistance to interferon alpha in vivo: first clinical dataT Moritz, O Kloke, M Nagel-Hiemke, et al.
BMC Cancer|June 23, 2010
Necrosis related HIF-1alpha expression predicts prognosis in patients with endometrioid endometrial carcinomaLaura M S Seeber, Nicole Horrée, Petra van der Groep, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 12, 2002
Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancerD Strumberg, S Brügge, M W Korn, et al.
European Journal of Cancer (Oxford, England : 1990)|January 24, 2006
Pooled safety analysis of BAY 43-9006 (sorafenib) monotherapy in patients with advanced solid tumours: Is rash associated with treatment outcome?D Strumberg, A Awada, H Hirte, et al.
Cancer Research|June 13, 2000
Differential susceptibility of renal carcinoma cell lines to tumor suppression by exogenous Fhit expressionN S Werner, Z Siprashvili, L Y Fong, et al.
Annals of Hematology|December 2, 2000
Long-term survival after induction therapy with idarubicin and cytosine arabinoside for de novo acute myeloid leukemiaM Flasshove, P Meusers, J Schütte, et al.
Pageof 30